However, heterozygous carriers of mutations in Mre11, Rad50, Nbs1/Nbn have only a small increase in cancer incidence over the lifecourse (Bartkova et al., 2008; Kuusisto et al., 2011; Damiola et al., 2014). This evidence concerns the gene RAD50 and cancer.